Human biospecimens for oncology research
Select FFPE tissue, tissue microarrays and matched plasma for your study. Explore treatment-defined and molecularly characterized cohorts, with clinical records and whole-slide images available from our translational pathology repository.
Explore biospecimens for your study
High quality tissues deliver high quality research
Choose the sample format, then explore the cohorts and accompanying data available for your research.
Surgical tissue
FFPE blocks, sections & curls
Select primary tumors, metastases or normal tissue with the clinical and molecular characteristics your study requires. Explore pre-defined cohorts or discuss a selection built around your protocol.
Tissue microarrays
TMA blocks & slides
Evaluate biomarkers across multiple tissue cores on a single slide. Browse established oncology TMAs with collection-specific characterization, or discuss a custom array for your study.
Matched specimens
Double-spun plasma & FFPE tissue
Investigate circulating biomarkers alongside matched tumor tissue. Explore paired collections across eight cancer indications, with plasma or whole blood and FFPE tissue from the same donor.
The featured paired collection is sourced from Ukraine and does not include outcome data.
Clinical & molecular context
Select tissue with the donor profiles your study needs
Build FFPE cohorts around disease characteristics, treatment history and available follow-up. Our tissue repository includes surgical specimens from participating medical centers in the UK, Italy and France, collected with informed consent and ethics approval.
Breadth of donor profiles
Specimen, treatment, outcomes and molecular data, structured at the patient level.
Patient trajectory
- Primary tumors & matched distant metastases
- Matched normal tissue
- Neoadjuvant & adjuvant treatment
- Standard-of-care targeted therapies & checkpoint inhibitors
- Treatment regimen, line & dates
- Responders & non-responders
Structured outcomes
- Clinician-recorded response
- Overall survival (months)
- Progression-free survival (months)
- Time to events (months)
- Last follow-up
- Event flags: recurrence / death / composite
Molecular characterization
- IHC
- FISH
- RNA-ISH
- NGS: SNVs, CNVs & fusions
Treatment context
- Checkpoint inhibitors & IO
- Antibodies & ADCs
- Kinase inhibitors
- CDK4/6 inhibitors
- PI3K/mTOR inhibitors
- PARP inhibitors
Records are fully anonymized. Available fields vary by donor and reflect clinical practice at the source center. Cohorts are selected to meet your project’s requirements.
TISSUE COLLECTIONS
Explore tissue collections
by indication
- Collections
- 31
- TMAs in these collections
- 271
- FFPE cohort profiles
- 63
Compare tissue microarrays and documented FFPE cohort profiles. Open a collection to explore the tissue, patient profiles and associated data.
- TMAs
- 16
- FFPE cohort profiles
- 2
- TMAs
- 27
- FFPE cohort profiles
- 7
- TMAs
- 5
- FFPE cohort profiles
- 0
- TMAs
- 5
- FFPE cohort profiles
- 0
- TMAs
- 62
- FFPE cohort profiles
- 6
- TMAs
- 4
- FFPE cohort profiles
- 2
- TMAs
- 13
- FFPE cohort profiles
- 4
- TMAs
- 5
- FFPE cohort profile
- 1
- TMAs
- 2
- FFPE cohort profiles
- 0
- TMAs
- 17
- FFPE cohort profiles
- 3
- TMAs
- 4
- FFPE cohort profile
- 1
- TMAs
- 7
- FFPE cohort profile
- 1
- TMAs
- 23
- FFPE cohort profiles
- 3
- TMAs
- 16
- FFPE cohort profile
- 1
- TMA
- 1
- FFPE cohort profiles
- 0
- TMAs
- 11
- FFPE cohort profiles
- 4
- TMAs
- 53
- FFPE cohort profiles
- 13
- TMAs
- 15
- FFPE cohort profiles
- 2
- TMAs
- 5
- FFPE cohort profiles
- 0
- TMAs
- 33
- FFPE cohort profiles
- 0
- TMAs
- 4
- FFPE cohort profiles
- 0
- TMAs
- 31
- FFPE cohort profiles
- 0
- TMAs
- 18
- FFPE cohort profiles
- 4
- TMAs
- 16
- FFPE cohort profile
- 1
- TMAs
- 22
- FFPE cohort profiles
- 5
- TMAs
- 14
- FFPE cohort profiles
- 3
- TMAs
- 6
- FFPE cohort profiles
- 0
- TMAs
- 4
- FFPE cohort profiles
- 0
- TMA
- 1
- FFPE cohort profiles
- 0
- TMAs
- 6
- FFPE cohort profiles
- 0
- TMAs
- 3
- FFPE cohort profiles
- 0
No collections match your search
Try another indication or show all collections.
TMA counts show cataloged arrays; FFPE counts show documented cohort profiles. Counts do not indicate sample quantities or current availability. Other FFPE tissue requirements can be discussed with our team.
Image & clinical data repository
Whole-slide images linked to the source tissue
Explore more than 100,000 H&E whole-slide images from 30,000 donors, linked to anonymized clinical records and archived FFPE tissue.
Select cases by tumor type, treatment and outcome for computational pathology and translational oncology research.
Assays & pathology support
Integrated tissue assay services
Pair selected FFPE tissue and TMAs with assays and pathology guidance, planned around your study.
Protein expression
IHC assay services
Add protein-expression measurements with 100+ optimized IHC assays, or discuss assay development for a new target.
Explore IHC servicesSpatial RNA expression
RNAscope RNA-ISH
Localize target RNA in FFPE tissue, with pre-qualified samples, assay controls and pathologist scoring.
Explore RNAscopeMultiplex protein imaging
Multiplex immunofluorescence
Study protein co-expression, cell phenotypes and spatial relationships in selected FFPE tissue and TMAs.
100+ optimized IHC assays
Selected targets from the IHC library. Multiplex panels are reviewed separately.
Browse the IHC target library →IHC staining on Ventana and Dako platforms. Review and scoring by medical pathologists with pharmaceutical industry experience.
Work with our experienced scientific team to tailor biospecimens, data, and integrated services to your research needs.
Our approach begins with our customers’ science.
We focus our acquisition on patient cohorts that meet the needs of biopharma, clinical, and translational researchers.
Plan your study
Tell us the cohort your study needs
Share your cancer indication, donor count, sample format and clinical or molecular criteria. We’ll review suitable repository specimens, available data and any additional work your study requires.